TNFSF11 antibody

Synonyms:Tumor necrosis factor ligand superfamily member 11|Osteoclast differentiation factor (ODF)|Osteoprotegerin ligand (OPGL)|Receptor activator of nuclear factor kappa-B ligand (RANKL)|TNF-related activation-induced cytokine (TRANCE)|Tumor necrosis factor ligand superfamily member 11 antibody, membrane form|Tumor necrosis factor ligand superfamily member 11 antibody, soluble form|TNFSF11|OPGL|RANKL|TRANCE antibody
Catalogue No.:FNab07108Reactivity:Human, Mouse, Rat
Host:RabbitTested Application:ELISA, WB, IHC, IF
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
Product Name
TNFSF11 antibody
Catalogue No.
FNab07108
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months (Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
tumor necrosis factor (ligand) superfamily, member 11
Alternative Names
Tumor necrosis factor ligand superfamily member 11|Osteoclast differentiation factor (ODF)|Osteoprotegerin ligand (OPGL)|Receptor activator of nuclear factor kappa-B ligand (RANKL)|TNF-related activation-induced cytokine (TRANCE)|Tumor necrosis factor ligand superfamily member 11 antibody, membrane form|Tumor necrosis factor ligand superfamily member 11 antibody, soluble form|TNFSF11|OPGL|RANKL|TRANCE antibody
UniProt ID
O14788
Observed MW
32 kDa
Application
Tested Applications
ELISA, WB, IHC, IF
Recommended dilution
WB: 1:500 - 1:2000; IHC: 1:50 - 1:200; IF: 1:50 - 1:200
Validated Images
COLO 320 cells were subjected to SDS PAGE followed by western blot with FNab07108( RANKL Antibody) at dilution of 1:1000
Immunohistochemistry of paraffin-embedded human colon tissue slide using FNab07108( RANKL Antibody) at dilution of 1:100
Background
This gene encodes a member of the tumor necrosis factor (TNF) cytokine family which is a ligand for osteoprotegerin and functions as a key factor for osteoclast differentiation and activation. This protein was shown to be a dentritic cell survival factor and is involved in the regulation of T cell-dependent immune response. T cell activation was reported to induce expression of this gene and lead to an increase of osteoclastogenesis and bone loss. This protein was shown to activate antiapoptotic kinase AKT/PKB through a signaling complex involving SRC kinase and tumor necrosis factor receptor-associated factor (TRAF) 6, which indicated this protein may have a role in the regulation of cell apoptosis. Targeted disruption of the related gene in mice led to severe osteopetrosis and a lack of osteoclasts. The deficient mice exhibited defects in early differentiation of T and B lymphocytes, and failed to form lobulo-alveolar mammary structures during pregnancy. Two alternatively spliced transcript variants have been found.